Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 06 • 04:00PM ET

9.47

+0.26 2.82 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: MRNA AMGN VRTX JNJ REGN GILD BMRN PFE BMY NVAX

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.66	Insider Own	39.77%	Shs Outstand	60.39M	Perf Week	12.74%
Market Cap	573.22M	Forward P/E	-	EPS next Y	-2.98	Insider Trans	1.02%	Shs Float	36.45M	Perf Month	1.50%
Enterprise Value	323.00M	PEG	-	EPS next Q	-0.75	Inst Own	41.64%	Short Float	11.61%	Perf Quarter	24.28%
Income	-161.31M	P/S	-	EPS this Y	16.12%	Inst Trans	23.00%	Short Ratio	5.08	Perf Half Y	37.65%
Sales	0.00M	P/B	2.46	EPS next Y	2.51%	ROA	-53.64%	Short Interest	4.23M	Perf YTD	0.74%
Book/sh	3.85	P/C	2.05	EPS next 5Y	12.50%	ROE	-64.67%	52W High	13.67 -30.72%	Perf Year	371.14%
Cash/sh	4.61	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-62.68%	52W Low	1.92 393.23%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.90% 8.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.71%	Oper. Margin	-	ATR (14)	0.74	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.18	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.75	EPS Q/Q	7.59%	SMA20	1.35%	Beta	2.07	Target Price	29.60
Payout	-	Debt/Eq	0.12	Sales Q/Q	-	SMA50	7.41%	Rel Volume	0.70	Prev Close	9.21
Employees	130	LT Debt/Eq	0.11	Earnings	Mar 26 AMC	SMA200	33.13%	Avg Volume	832.88K	Price	9.47
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% -	Trades		Volume	588,142	Change	2.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)